SkylinePro

IBB - Biotech ETF could offer good potential

ロング
SkylinePro アップデート済   
NASDAQ:IBB   iShares Biotechnology ETF
IBB seems to have starting minor wave 5 up that could lead its price to the most probable target of 134.00. This sector should be be one of the good options to be in during the current market scenario. If prices crosses down 199.70, this analysis should be reviewed. FOLLOW SKYLINEPRO TO GET UPDATES.
トレード終了: 利益確定目標に到達:
Prices reached 134.60 and should be start a correction to around the most probable target of 115.00. If prices crosses up 136, this scenario should be reviewed. See updated post

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。